Pillstats
Rx only · Tablet, Film Coated · Oral

Thioridazine Hydrochloride

Thioridazine Hydrochloride

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US20 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10502
US makers5 labelers
Packages29
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.186$0.373$0.559$0.745Dec 2025Apr 2026Jul 2026
$0.648
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
5
Active US suppliers
59%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6241.2K1.9K2.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.7K
Rx · 2026 Q1
131K
Units dispensed
-22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown13SUPPLYING
Mylan Institutional LLCunknown4SUPPLYING
Mylan Pharmaceuticals Inc.unknown4SUPPLYING
Safecor Health, LLCunknown4SUPPLYING
Chartwell RX, LLCunknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.